Revenue Beats, Guidance Reaffirmed — Consumer Ramp Will Decide the Year
Aequs grew revenue 55% in Q1, beating guidance, with aerospace surging 40% and order book crossing USD 1 billion. Yet a ₹53 crore net loss and management's refusal to raise full-year targets reveal the core doubt: can consumer utilization nearly double in three quarters to hit Q4 EBITDA breakeven?
₹395.5 Cr
+55% YoY, +7.7% QoQ; beats 45–50% FY27 guidance
-₹53.2 Cr
NPM -13.2%; despite revenue growth
₹148 Cr
+3.5x QoQ from ₹42 Cr; 3.7% margin ex-FX
40% YoY
₹322.2 Cr at 23% EBITDA margin; beats 25–30% guidance
Aequs grew revenue 55% to ₹395.5 crore, beating its FY27 guidance of 45–50%, with aerospace delivering 40% growth and consumer 190% growth. Yet it reported a ₹53.2 crore net loss, and reaffirmed full-year guidance rather than raising it. The gap between headline growth and headline loss is where this quarter's real story sits.
Why the net loss despite 55% revenue growth
The reported EBITDA of ₹215 crore is misleading. Strip out the ₹67 crore other income (down ₹212 crore from Q4 on forex swings) and operational EBITDA is ₹148 crore—the real number and improving 3.5x. But then three items drag net profit into red: depreciation ₹453 crore (up 84% YoY) from consumer capex capitalization reaching the P&L, finance cost ₹189 crore, and consumer segment EBITDA loss ₹361 crore. Aerospace is profitable; the loss is entirely consumer's burden.
Management's claims: what holds up
Revenue grew 55% YoY
Supported₹395.5 Cr delivered; beats 45–50% FY27 guidance on aerospace (40%) and consumer (190%)
Operating EBITDA improved 3.5x sequentially
Supported₹42 Cr (Q4) → ₹148 Cr (Q1); operational improvement is real
Strong start translating expanded capacity into financial returns
OverstatedNet loss ₹53.2 Cr despite revenue beat; consumer EBITDA loss ₹361 Cr contradicts profitability narrative
Aerospace delivered 40% YoY growth at 23% EBITDA margin
Supported₹322.2 Cr revenue, 23% margin; beats FY27 guidance of 25–30% growth and >20% margin
Consumer EBITDA breakeven by Q4 FY27 has first proof point
PartialLoss narrowed ₹112 Cr sequentially (₹473 Cr → ₹361 Cr); path valid but unproven. Requires utilization 22% → 40–50% in 3 quarters
What changed on this call
The Safran A320 wheels contract is the strategic win—15-year agreement, single-source, first A320 wheel outsourcing, 100% Make in India. The order book crossed USD 1 billion (up from USD 889 Cr Q4), a milestone. Aerospace is running 40% growth at 23% margin, beating guidance on both fronts. But management reaffirmed FY27 guidance rather than raising it, a caution signal given the Q1 beat on every metric. Consumer showed a utilization paradox: revenue grew 16% QoQ (₹73.4 Cr) but utilization fell from 23% (Q4) to 22% (Q1). Management attributed this to better yield/mix rather than capacity under-utilization—a claim that needs watching. Consumer EBITDA loss narrowed ₹112 crore sequentially (₹473 Cr → ₹361 Cr, a 24% improvement), validating the trajectory but not yet proving Q4 breakeven is secure.
The bull-bear case
Aerospace segment running 40% growth at 23% EBITDA margin; beats both guidance metrics
Order book crossed USD 1B; Safran contract validates market trust and differentiation
Consumer EBITDA loss narrowing sequentially (₹112 Cr improvement); Q4 breakeven path on track if utilization ramps
Revenue beat guidance (55% vs 45–50% FY27 forecast) on robust aerospace and consumer nearshoring tailwinds
Operational EBITDA +3.5x sequentially; operational momentum is real
Reported net loss ₹53.2 Cr despite ₹395.5 Cr revenue (+55% growth)—real profitability gap
Consumer EBITDA loss still ₹361 Cr; must halve again by Q4 FY27 to hit breakeven
Consumer utilization 22% today; must reach 40–50% by Q4 (3 quarters) for breakeven. Near-doubling in 3 qtrs is execution-dependent, high-risk
Depreciation burden ₹453 Cr (capex tail) will persist through FY27; earnings severely burdened until consumer revenue scales 2–3x
Management reaffirmed rather than raised guidance despite Q1 beat—cautious posturing signals execution uncertainty
Operating cash flow negative ₹414 Cr despite revenue growth; company burning cash to fuel ramp
99% raw material imported; only 2 aluminum alloy grades qualified in India. Tariff and supply chain risk
Unnamed large consumer electronics OEM concentration; Mattel secondary. One customer loss would hurt consumer segment badly
Risks, ranked by holder concern
Consumer utilization ramp execution
HighConsumer is at 22% utilization; must reach 40–50% by Q4 FY27 (3 quarters) to hit EBITDA breakeven as guided. Near-doubling in 3 quarters is a stretch goal. If ramp stalls, breakeven slips, losses extend, and FY27 targets miss. Analyst skepticism on credibility: revenue +16% QoQ but utilization fell 1 point, suggesting yield/mix gains may mask under-utilization.
Profitability timing despite revenue growth
HighNet loss ₹53.2 Cr despite ₹395.5 Cr revenue is a red flag on how far away consolidated profitability is. Depreciation ₹453 Cr will persist; consumer losses will cap reported earnings until consumer revenue scales 2–3x from ₹73.4 Cr. Management expects consumer breakeven by Q4 but no PAT margin % committed until FY31. Path is long.
Raw material import concentration
Medium99% of raw materials imported; only 2 aluminum alloy grades and limited super-alloys qualified in India for aerospace. Tariff escalation or supply disruption could constrain margin expansion or supply security. Long ecosystem development timeline; unlikely to change soon.
Forex volatility masking operational reality
MediumOther income fell ₹212 Cr QoQ (Q4: ₹279 Cr, Q1: ₹67 Cr) mainly on forex swings. Large volatility obscures operational margin improvement and complicates guidance credibility. Management states forex not projected; focus on operational EBITDA. But unhedged exposure implies continued unpredictability.
Customer concentration in consumer segment
MediumUnnamed large global consumer electronics OEM is bulk of consumer electronics revenue (confidentiality cited). Mattel (toys) and Tramontina (durables) secondary. Heavy reliance on single OEM creates concentration risk. No customer loss mitigation disclosed.
How the street is positioned
The market's initial reaction on day 1 post-announcement (July 29) was muted—stock fell 0.32%—but by day 5 it had rallied +4.73%, suggesting investors looked through the headline loss to the operational and order-book story. This is a bullish signal: the market validated the fundamentals beneath the loss. The stock now trades at ₹249.64, up 120% from its 52-week low but 9% below its all-time high, on a BULLISH trend with RSI 66.5 (neutral territory). Valuation-wise, the stock is near ATH despite being loss-making, pricing in consumer Q4 FY27 breakeven and sustained aerospace momentum. Ownership shifts are mixed: FII ownership rose 126bp to 5.16% (foreign institutional investors rotating in), while DII trimmed 253bp to 8.85% (domestic institutions taking some chips off the table). The divergence—foreign buying, domestic caution—suggests sophisticated foreign investors are betting on consumer execution while local institutions hedge their bets.
1 · Q2–Q3 FY27: Consumer utilization ramp to 30–40%
Track the utilization trajectory and EBITDA loss trajectory in parallel. If utilization climbs but loss doesn't narrow proportionally, yield/mix gains are overstated and ramp may be slower than expected.
2 · Q2 FY27 order book update: New Farnborough contracts
Safran wheels revenue ramp and Tier-1 aerostructure wins. Order book >USD 1.1B signals new customer deals converting. This validates aerospace momentum persistence.
3 · Q4 FY27: Consumer EBITDA breakeven inflection
The do-or-die moment. If achieved, step to consolidated profitability clears and FY28 margin guidance gains credibility. If missed, Q4 loss extension signals utilization ramp is stalling and FY27 targets slip.
4 · FY27–FY28: Hosur facility commissioning
First phase of ₹1,900 Cr 10-year vertical integration play. Sep–Mar FY27–FY28 timeline. Revenue ramp FY29 (engine components, landing gear). Delay or capex overrun signals execution risk on capital allocation.
Aequs is in steady execution mode, not a step-change quarter. Aerospace momentum is genuine and profitable; consumer is ramping on structural nearshoring tailwinds (190% YoY growth) but still unprofitable and unproven on the Q4 breakeven bet. The reported ₹53.2 crore loss is a near-term earnings drag (depreciation tail + consumer EBITDA loss), but operational EBITDA is improving 3.5x and order book >USD 1B validates sustained demand. Management's refusal to raise FY27 guidance despite beating Q1 is caution, not weakness—it signals confidence in the targets but not overconfidence on delivery risk.
The single number to track from here is consumer EBITDA loss trajectory. If it narrows to ₹350 Cr by Q2, ₹300 Cr by Q3, and breakeven by Q4, the path holds and FY28 profitability is assured. If loss stalls or widens, it signals utilization ramp is slower than expected and the year's targets slip. That will define whether aerospace momentum alone is enough to justify the current valuation. Until consumer proves Q4 breakeven, hold for aerospace execution and watch consumer as the risk lever.
Informational and educational content only. Not investment advice.